Skip to main content
. 2022 Jul 22;2022(7):CD013705. doi: 10.1002/14651858.CD013705.pub3

Beck 2021.

Study characteristics
Patient Sampling Single‐group study estimating sensitivity and specificity: all patients with signs and symptoms of COVID‐19 presenting to an urgent care centre (n = 347)
Recruitment: consecutive ("all patients")
Prospective or retrospective: not stated; appears prospective
Sample size (cases): 347 (61)
Patient characteristics and setting Setting: urgent care centre
Location: Advocate Aurora Health Urgent Care Center, West Bend, WI
Country: USA
Dates: not stated
Symptoms and severity: all symptomatic; no further details
Demographics: age range 1‐90 years; ≤ 18 years 35.4%, 19‐50 years 38.3%, > 50 years 26.2% of participants
Exposure history: not reported
Index tests Test name: SOFIA SARS Antigen FIA
Manufacturer: Quidel
Antibody: SARS‐CoV
Ag target: not reported
Test method: FIA
Samples used: nasal; collection not described but appears to be HCW ("providers" mentioned in acknowledgements). IFU describes NMT samples
Transport media: none; "swabs were carefully returned to the paper envelope in which they came and were placed in a sealed plastic specimen transport bag"
Sample storage: none; "specimens were delivered to the laboratory (located within the same building) within 10 minutes of collection"
Test operator: lab staff
Definition of test positivity: not stated; "tested … according to the manufacturer’s package insert"
Blinding reported: yes; done first and in separate lab
Timing of samples: ≤ 5 days pso 298, 86.1%; > 5 days pso 48, 13.9%
Target condition and reference standard(s) Reference standard: transcription‐mediated amplification (TMA); Hologic Aptima Panther SARS‐CoV‐2 TMA test.
Cepheid Xpert Xpress SARS‐CoV‐2 RT‐PCR used for discrepant samples (after approx. 3 weeks' frozen storage)
Definition of non‐COVID cases: as for cases
Genetic target(s): not stated
Samples used: NP in Amies bacterial transport medium (Copan, Brescia, Italy)
Timing of reference standard: as for index test
Blinded to index test: not stated; specimens were refrigerated and sent via courier to the central laboratory of ACL Laboratories
Incorporated index test: no
Flow and timing Time interval between index and reference tests: simultaneous; paired swabs, NP collected first
All participants received same reference standard: yes
Missing data: 1 sample only (low risk)
Uninterpretable results: 1 sample invalid on SOFIA
Indeterminate results (index test): none reported
Indeterminate results (reference standard): none reported.
Discrepant analysis: 2/14 FNs were negative on Xpert Xpress; 1/1 FPs also negative Xpert Xpress
Unit of analysis: participant
Comparative  
Notes Funding: none reported
Publication status: published
Source: Journal of Clinical Microbiology
Author COI: none reported
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes    
Was a case‐control design avoided? Yes    
Did the study avoid inappropriate inclusions? Yes    
Could the selection of patients have introduced bias?   Low risk  
Are there concerns that the included patients and setting do not match the review question?     Low concern
DOMAIN 2: Index Test (Evaluations of single test application)
Were the index test results interpreted without knowledge of the results of the reference standard? Yes    
If a threshold was used, was it pre‐specified? Yes    
Could the conduct or interpretation of the index test have introduced bias?   Low risk  
Are there concerns that the index test, its conduct, or interpretation differ from the review question?     Low concern
DOMAIN 2: Index Test (Evaluations of serial (repeat) testing)
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? No    
Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear    
Reference standard does not incorporate result of index test? Yes    
Could the reference standard, its conduct, or its interpretation have introduced bias?   High risk  
Are there concerns that the target condition as defined by the reference standard does not match the question?     High
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Yes    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? No    
Did all participants receive a reference standard? Yes    
Could the patient flow have introduced bias?   Low risk